FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093291263> ?p ?o ?g. }

• W2093291263 endingPage "273" @default.
• W2093291263 startingPage "265" @default.
• W2093291263 abstract "The neurobiology of methamphetamine (MA) remains largely unknown despite its high abuse liability. The present series of studies explored the role of adenosine receptors on MA reward and reinforcement and identified alterations in the expression of adenosine receptors in dopamine terminal areas following MA administration in rats. We tested whether stimulating adenosine A1 or A2A receptor subtypes would influence MA-induced place preference or MA self-administration on fixed and progressive ratio schedules in male Sprague–Dawley rats. Stimulation of either adenosine A1 or A2A receptors significantly reduced the development of MA-induced place preference. Stimulating adenosine A1, but not A2A, receptors reduced MA self-administration responding. We next tested whether repeated experimenter-delivered MA administration would alter the expression of adenosine receptors in the striatal areas using immunoblotting. We observed no change in the expression of adenosine receptors. Lastly, rats were trained to self-administer MA or saline for 14 days and we detected changes in adenosine A1 and A2A receptor expression using immunoblotting. MA self-administration significantly increased adenosine A1 in the nucleus accumbens shell, caudate-putamen and prefrontal cortex. MA self-administration significantly decreased adenosine A2A receptor expression in the nucleus accumbens shell, but increased A2A receptor expression in the amygdala. These findings demonstrate that MA self-administration produces selective alterations in adenosine receptor expression in the nucleus accumbens shell and that stimulation of adenosine receptors reduces several behavioral indices of MA addiction. Together, these studies shed light onto the neurobiological alterations incurred through chronic MA use that may aid in the development of treatments for MA addiction." @default.
• W2093291263 created "2016-06-24" @default.
• W2093291263 creator A5007978684 @default.
• W2093291263 creator A5023010090 @default.
• W2093291263 creator A5043776406 @default.
• W2093291263 creator A5048130286 @default.
• W2093291263 creator A5081844355 @default.
• W2093291263 date "2015-02-01" @default.
• W2093291263 modified "2023-10-01" @default.
• W2093291263 title "Role of adenosine receptor subtypes in methamphetamine reward and reinforcement" @default.
• W2093291263 cites W1576956032 @default.
• W2093291263 cites W1884088666 @default.
• W2093291263 cites W1968578851 @default.
• W2093291263 cites W1969470553 @default.
• W2093291263 cites W1976530828 @default.
• W2093291263 cites W1977592396 @default.
• W2093291263 cites W1977651920 @default.
• W2093291263 cites W1978016359 @default.
• W2093291263 cites W1981095733 @default.
• W2093291263 cites W1983420992 @default.
• W2093291263 cites W1984450517 @default.
• W2093291263 cites W1984975608 @default.
• W2093291263 cites W1987441723 @default.
• W2093291263 cites W2005969184 @default.
• W2093291263 cites W2006293323 @default.
• W2093291263 cites W2007393690 @default.
• W2093291263 cites W2012524024 @default.
• W2093291263 cites W2013836047 @default.
• W2093291263 cites W2015252734 @default.
• W2093291263 cites W2018506506 @default.
• W2093291263 cites W2022925219 @default.
• W2093291263 cites W2023171075 @default.
• W2093291263 cites W2024078494 @default.
• W2093291263 cites W2024469932 @default.
• W2093291263 cites W2026375042 @default.
• W2093291263 cites W2026913847 @default.
• W2093291263 cites W2026926773 @default.
• W2093291263 cites W2033564079 @default.
• W2093291263 cites W2035974648 @default.
• W2093291263 cites W2036279988 @default.
• W2093291263 cites W2042726027 @default.
• W2093291263 cites W2046525307 @default.
• W2093291263 cites W2048579467 @default.
• W2093291263 cites W2048969819 @default.
• W2093291263 cites W2060183829 @default.
• W2093291263 cites W2073345931 @default.
• W2093291263 cites W2075305798 @default.
• W2093291263 cites W2077150252 @default.
• W2093291263 cites W2079329230 @default.
• W2093291263 cites W2083481882 @default.
• W2093291263 cites W2084663298 @default.
• W2093291263 cites W2084837506 @default.
• W2093291263 cites W2087754468 @default.
• W2093291263 cites W2087881873 @default.
• W2093291263 cites W2089811657 @default.
• W2093291263 cites W2095169653 @default.
• W2093291263 cites W2119287288 @default.
• W2093291263 cites W2120077675 @default.
• W2093291263 cites W2125699355 @default.
• W2093291263 cites W2127188314 @default.
• W2093291263 cites W2136306454 @default.
• W2093291263 cites W2144176813 @default.
• W2093291263 cites W2145758516 @default.
• W2093291263 cites W2156094804 @default.
• W2093291263 cites W2159427608 @default.
• W2093291263 cites W2163320407 @default.
• W2093291263 cites W2164436828 @default.
• W2093291263 cites W275651249 @default.
• W2093291263 cites W4254566369 @default.
• W2093291263 doi "https://doi.org/10.1016/j.neuropharm.2014.09.030" @default.
• W2093291263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4250385" @default.
• W2093291263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25301277" @default.
• W2093291263 hasPublicationYear "2015" @default.
• W2093291263 type Work @default.
• W2093291263 sameAs 2093291263 @default.
• W2093291263 citedByCount "21" @default.
• W2093291263 countsByYear W20932912632015 @default.
• W2093291263 countsByYear W20932912632016 @default.
• W2093291263 countsByYear W20932912632017 @default.
• W2093291263 countsByYear W20932912632018 @default.
• W2093291263 countsByYear W20932912632019 @default.
• W2093291263 countsByYear W20932912632020 @default.
• W2093291263 countsByYear W20932912632021 @default.
• W2093291263 countsByYear W20932912632022 @default.
• W2093291263 countsByYear W20932912632023 @default.
• W2093291263 crossrefType "journal-article" @default.
• W2093291263 hasAuthorship W2093291263A5007978684 @default.
• W2093291263 hasAuthorship W2093291263A5023010090 @default.
• W2093291263 hasAuthorship W2093291263A5043776406 @default.
• W2093291263 hasAuthorship W2093291263A5048130286 @default.
• W2093291263 hasAuthorship W2093291263A5081844355 @default.
• W2093291263 hasBestOaLocation W20932912632 @default.
• W2093291263 hasConcept C126322002 @default.
• W2093291263 hasConcept C134018914 @default.
• W2093291263 hasConcept C15744967 @default.
• W2093291263 hasConcept C16587737 @default.
• W2093291263 hasConcept C169760540 @default.
• W2093291263 hasConcept C170493617 @default.

• next